0001019056-13-001022.txt : 20130909 0001019056-13-001022.hdr.sgml : 20130909 20130909181520 ACCESSION NUMBER: 0001019056-13-001022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130615 FILED AS OF DATE: 20130909 DATE AS OF CHANGE: 20130909 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aegerion Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001338042 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202960116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 MAIN STREET STREET 2: SUITE 1850 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 500-7867 MAIL ADDRESS: STREET 1: 101 MAIN STREET STREET 2: SUITE 1850 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Aegerion Pharmaceuticals Inc DATE OF NAME CHANGE: 20050906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERCEPTIVE LIFE SCIENCES MASTER FUND LTD CENTRAL INDEX KEY: 0001249675 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34921 FILM NUMBER: 131086546 BUSINESS ADDRESS: STREET 1: C/O PERCEPTIVE ADVISORS LLC STREET 2: 499 PARK AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646-205-5340 MAIL ADDRESS: STREET 1: C/O PERCEPTIVE ADVISORS LLC STREET 2: 499 PARK AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EDELMAN JOSEPH CENTRAL INDEX KEY: 0001164426 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34921 FILM NUMBER: 131086547 MAIL ADDRESS: STREET 1: PERCEPTIVE ADVISORS LLC STREET 2: 499 PARK AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERCEPTIVE ADVISORS LLC CENTRAL INDEX KEY: 0001224962 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34921 FILM NUMBER: 131086548 BUSINESS ADDRESS: STREET 1: 499 PARK AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646-205-5340 MAIL ADDRESS: STREET 1: 499 PARK AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 4 1 perceptive_4.xml OWNERSHIP DOCUMENT X0306 4 2013-06-15 1 0001338042 Aegerion Pharmaceuticals, Inc. AEGR 0001224962 PERCEPTIVE ADVISORS LLC 499 PARK AVENUE 25TH FLOOR NEW YORK NY 10022 0 0 1 0 0001164426 EDELMAN JOSEPH C/O PERCEPTIVE ADVISORS LLC 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 0 0 1 0 0001249675 PERCEPTIVE LIFE SCIENCES MASTER FUND LTD C/O PERCEPTIVE ADVISORS LLC 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 0 0 1 0 Common Stock 2013-06-15 4 X 0 100000 25 A 3473426 I See Footnotes Common Stock 2013-06-15 4 X 0 100000 25 A 3573426 I See Footnotes Common Stock 2013-09-05 4 S 0 700000 89.2 D 2873426 I See Footnotes Common Stock 2013-09-05 4 S 0 50000 89.2 D 2823426 I See Footnotes Call option (right to buy) 25 2013-06-15 4 X 0 1000 0 D 2013-06-15 2013-06-15 Common Stock 100000 1000 I See Footnotes Call option (right to buy) 25 2013-06-15 4 X 0 1000 0 D 2013-06-15 2013-06-15 Common Stock 100000 0 I See Footnotes This Form 4 is being filed by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"), Perceptive Advisors LLC (the "Advisor") and Joseph Edelman. The Advisor serves as investment manager to the Master Fund and to a managed account (the "Managed Account") for BioEdelman LLC, an entity directly owned by Mr. Edelman. Mr. Edelman is the managing member of the Advisor. This transaction reflects the exercise of an in-the-money option by the Advisor on behalf of the Master Fund. This transaction reflects the exercise of an in-the-money option by the Advisor on behalf of the Managed Account. This transaction reflects the sale of securities by the Advisor on behalf of the Master Fund. This transaction reflects the sale of securities by the Advisor on behalf of the Managed Account. This amount reflects the total amount of securities held by the Master Fund and the Managed Account immediately following the transaction requiring the filing of this statement. In accordance with Instruction 5(b)(iv) of Form 4, the entire amount of the Issuer's securities held by the Master Fund and the Managed Account is reported herein. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. /s/ Joseph Edelman, managing member of Perceptive Advisors LLC 2013-09-09 EX-24 2 ex_24.txt EXHIBIT 24 Exhibit 24 Information Regarding Joint Filers Designated Filer of Form 4: Perceptive Advisors LLC Date of Earliest Transaction Required to be Reported: June 15, 2013 Issuer Name and Ticker Symbol: Aegerion Pharmaceuticals, Inc. [AEGR] Names: Perceptive Life Sciences Master Fund Ltd. and Joseph Edelman Address: Perceptive Advisors LLC 499 Park Avenue, 25th Floor New York, NY 10022 Signatures: The undersigned, Perceptive Life Sciences Master Fund Ltd. and Joseph Edelman, are jointly filing the attached Statement of Changes in Beneficial Ownership of Securities on Form 4 with Perceptive Advisors LLC with respect to the beneficial ownership of securities of Aegerion Pharmaceuticals, Inc. Perceptive Life Sciences Master Fund Ltd. By: Perceptive Advisors LLC, its investment manager By: /s/ Joseph Edelman ------------------------------------------------- Joseph Edelman, managing member JOSEPH EDELMAN By: /s/ Joseph Edelman -------------------------------------------------- Joseph Edelman